Using the mycelium-covered cereals as an efficient inoculation method for rapamycin fermentation in a 15-L fermenter using Streptomyces hygroscopicus

Abstract

Background

Rapamycin is produced from Streptomyces hygroscopicus, and was initially identified as an antifungal antibiotic. More recently, rapamycin has been found to have various medical applications, including in relation to immunosuppression and anti-aging. Due to its complex structure, biological production is the major route for commercialized rapamycin production. The conventional fermentation process requires a large seed fermenter for the inoculation process (in general, the volume of the seed fermenter is equal to 5–10 % that of the production fermenter), which presents challenges with regard to scaling up production, due to the high investment costs of seed fermenters. This study explored different inoculation strategies for rapamycin production in a 15-L agitation fermenter.

Results

The results indicated that solid-state fermentation (SSF) using barley as the substrate is a suitable method for the inoculation. The highest rapamycin concentration measured in the batch with SSF (barley) inoculated was about 520 mg/L, which was significantly higher than that of 400 mg/L obtained in the batch inoculated with 5 % liquid seed medium. Besides the higher rapamycin production, using SSF of barley as the inoculation method can greatly reduce both the labor and cost requirements.

Conclusions

The usage of mycelium-covered barley as the solid substrate for the inoculation of 15-L fermenter leading to a higher rapamycin production compared to that of conventional liquid seed medium. The solid-state inoculation method can avoid both the intensive labor requirement and costly seed fermenter needed with the latter approach. This inoculation method thus has the potential to be applied to the large-scale production of rapamycin.

Keywords

Inoculation / Morphology / Solid-state fermentation / Rapamycin

References

[1] Casas Lopez JL, Sanchez Perez JA, Fernandez Sevilla JM, Rodriguez Porcel EM, Chisti Y. Pellet morphology, culture rheology and lovastatin production in cultures of Aspergillus terreus. J Biotechnol, 2005, 116: 61-77.

[2] Chen Y, . New process control strategy used in a rapamycin fermentation. Process Biochem, 1999, 34: 383-389.

[3] Chen Y, Krol J, Huang W, Cino JP, Vyas R, Mirro R, . DCO2 on-line measurement used in rapamycin fed-batch fermentation process. Process Biochem, 2008, 43: 351-355.

[4] Choi DB, Park EY, Okabe M. Improvement of tylosin production from Streptomyces fradiae culture by decreasing the apparent viscosity in an air-lift bioreactor. J Ferment Bioeng, 1998, 86: 413-417.

[5] Dobson LF, O’Cleirigh CC, O’Shea DG. The influence of morphology on geldanamycin production in submerged fermentations of Streptomyces hygroscopicus var. geldanus. Appl Microbiol Biotechnol, 2008, 79: 859-866.

[6] El-Sabbagh N, McNeil B, Harvey LM. Dissolved carbon dioxide effects on growth, nutrient consumption, penicillin synthesis and morphology in batch cultures of Penicillium chrysogenum. Enzym Microbial Technol, 2006, 39: 185-190.

[7] Fang QH, Tang YJ, Zhong JJ. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochem, 2002, 37: 1375-1379.

[8] Ilić SB, Konstantinović SS, Veljković VB, Savić DS, Lazić, Gojgić-Cvijović G. Impact of carboxymethylcellulose on morphology and antibiotic production by Streptomyces hygroscopicus. Curr Microbiol, 2008, 57: 8-11.

[9] Jonsbu E, McIntyre M, Nielsen J. The influence of carbon sources and morphology on nystatin production by Streptomyces noursei. J Biotechnol, 2002, 95: 133-144.

[10] Kanda M, Yamamoto E, Hayashi A, Yabutani T, Yamashita M, Honda H. Scale-up fermentation of echinocandin type antibiotic FR901379. J Biosci Bioeng, 2010, 109: 138-144.

[11] Kojima I, Cheng YR, Mohan V, Demain AL. Carbon source nutrition of rapamycin biosynthesis in Streptomyces hygroscopicus. J Ind Microbiol Biotechnol, 1995, 14: 436-439.

[12] Kuhnt Michaela, Bitsch F, Ponelle M, Fehr T, Sanglier J-J. Microbial conversion of rapamycin. Enzym Microbial Technol, 1997, 21: 405-412.

[13] Lee M, Kojima I, Demain A. Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus. J Ind Microbiol Biotechnol, 1997, 19: 83-86.

[14] Pinto LS, Vieira LM, Pons MN, Fonseca MM, Menezes JC. Morphology and viability analysis of Streptomyces clavuligerus in industrial cultivation systems. Bioprocess Biosyst Eng, 2004, 26: 177-184.

[15] Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), A new antifungal antibiotic II. Fermentation, isolation and characterization. J Antibio, 1975, 28: 727-732.

[16] Tamura S, Park Y, Toriyama M, Okabe M. Change of mycelial morphology in tylosin production by batch culture of Streptomyces fradiae under various shear conditions. J Ferment Bioeng, 1997, 83: 523-528.

[17] Treskatis SK, Orgeldinger V, Wolf H, Gilles ED. Morphological characterization of filamentous microorganisms in submerged cultures by on-line digital image analysis and pattern recognition. Biotechnol Bioeng, 1997, 53: 191-201.

[18] Yang FC, Yang YH, Lu HC. Enhanced antioxidant and antitumor activities of Antrodia cinnamomea cultured with cereal substrates in solid state fermentation. Biochem Eng J, 2013, 78: 108-113.

[19] Yen HW, Hsiao HP. Effects of dissolved oxygen level on rapamycin production by pellet-form of Streptomyces hygroscopicus. J Biosci Bioeng, 2013, 116: 366-370.

[20] Yen HW, Li YL. The effects of viscosity and aeration rate on rapamycin production in an airlift bioreactor by using Streptomyces hygroscopicus. J Taiwan Inst Chem Eng, 2014, 45: 1149-1153.

[21] Yen HW, Hsiao HP, Chen LJ. The enhancement of rapamycin production using Streptomyces hygroscopicus through a simple pH-shifted control. J Taiwan Inst Chem Eng, 2013, 44: 743-747.

[22] Zhu X, Zhang W, Chen X, Wu H, Duan Y, Xu Z. Generation of High Rapamycin Producing Strain via Rational Metabolic Pathway-Based Mutagenesis and Further Titer Improvement With Fed-Batch BioprocessOptimization. Biotechnol Bioeng, 2010, 107: 506-515.

Funding

Taiwan’s Ministry of Science and Technology (MOST)(103-2623-E-029-001-ET and 102-2221-E-029-017-MY2)